Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy.
Suggest edits
Founded
2015
Raised
$134M
Follow us
Also headquartered in Cambridge
Companies in the same industry
Alexa global traffic share
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 3

Add info
Latest funding Show all
$85,000,000
Venture capital (Series C) - 2020
Omega Funds Longitude Capital Sectoral Asset Management +8
$22,000,000
Venture capital (Series C) - 2018
Team Size
1–10
Employees
I work here
Location
Cambridge ,  United States
Headquarters
Explore Cambridge
Pulse 2.0

Checkmate Pharmaceuticals (CMPI) Stock: Why The Price Increased Over 320% Today

Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
The
The
$85,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Checkmate Pharmaceuticals Raises $85M in Series C Financing

Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
$22,000,000 Venture capital (Series C)
FinSMEs

Checkmate Pharmaceuticals Closes $22M Financing

Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
$27,000,000 Venture capital (Series B)
businesswire , PE HUB , ENDPOINTS NEWS

Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating...